Javle MM - Search Results

1

Side effects of therapy: case 3. Gastric cancer after radiotherapy of pediatric Hodgkin's disease.

Palesty JA, Wang W, Javle MM, Yang GY. Palesty JA, et al. Among authors: javle mm. J Clin Oncol. 2004 Jun 15;22(12):2507-9. doi: 10.1200/JCO.2004.09.168. J Clin Oncol. 2004. PMID: 15197215 No abstract available.

2

Unusual locations of involvement by malignancies: Case 3. Gastric signet ring carcinoma presenting as a diffuse thigh mass.

Varma GN, Winston JS, Hill HC, Gibbs JF, Proulx GM, McGrath BE, Javle MM. Varma GN, et al. Among authors: javle mm. J Clin Oncol. 2003 Sep 1;21(17):3371-3. doi: 10.1200/JCO.2003.09.089. J Clin Oncol. 2003. PMID: 12947076 No abstract available.

3

Chemoradiation is a tolerable therapy for older adults with esophageal cancer.

Nallapareddy S, Wilding GE, Yang G, Iyer R, Javle M. Nallapareddy S, et al. Anticancer Res. 2005 Jul-Aug;25(4):3055-60. Anticancer Res. 2005. PMID: 16080565 Free article.

4

Neoadjuvant therapy for gastric cancer.

Chadha MK, Kuvshinoff BW, Javle MM. Chadha MK, et al. Among authors: javle mm. Oncology (Williston Park). 2005 Aug;19(9):1219-27; discussion 1227-8, 1231-2. Oncology (Williston Park). 2005. PMID: 16255136 Free article. Review.

5

Cyclooxygenase-2 (COX-2) levels before and after chemotherapy: a study in rectal cancer.

Watwe V, Javle M, Lawrence D, Groth J, Iyer R, El-Hajjar D, Geradts J. Watwe V, et al. Am J Clin Oncol. 2005 Dec;28(6):560-4. doi: 10.1097/01.coc.0000182476.34375.17. Am J Clin Oncol. 2005. PMID: 16317264

6

Palliation of malignant dysphagia in esophageal cancer: a literature-based review.

Javle M, Ailawadhi S, Yang GY, Nwogu CE, Schiff MD, Nava HR. Javle M, et al. J Support Oncol. 2006 Sep;4(8):365-73, 379. J Support Oncol. 2006. PMID: 17004508 Review.

7

Concurrent oxaliplatin, 5-fluorouracil, and radiotherapy in the treatment of locally advanced esophageal carcinoma.

O'Connor BM, Chadha MK, Pande A, Lombardo JC, Nwogu CE, Nava HR, Yang G, Javle MM. O'Connor BM, et al. Among authors: javle mm. Cancer J. 2007 Mar-Apr;13(2):119-24. doi: 10.1097/PPO.0b013e318046ee1a. Cancer J. 2007. PMID: 17476140

8

Review: neoadjuvant chemoradiotherapy and chemotherapy improve survival in operable esophageal cancer.

Javle M, Yang GY. Javle M, et al. ACP J Club. 2007 Jul-Aug;147(1):19. ACP J Club. 2007. PMID: 17608384 No abstract available.

9

Pilot study of gefitinib, oxaliplatin, and radiotherapy for esophageal adenocarcinoma: tissue effect predicts clinical response.

Javle M, Pande A, Iyer R, Yang G, LeVea C, Wilding G, Black J, Nava H, Nwogu C. Javle M, et al. Am J Clin Oncol. 2008 Aug;31(4):329-34. doi: 10.1097/COC.0b013e318161dc04. Am J Clin Oncol. 2008. PMID: 18845990 Clinical Trial.

10

Capecitabine, oxaliplatin and radiotherapy: a phase IB neoadjuvant study for esophageal cancer with gene expression analysis.

Javle MM, Yang G, Nwogu CE, Wilding GE, O'Malley L, Vinjamaram S, Schiff MD, Nava HR, LeVea C, Clark KR, Prey JD, Smith PF, Pendyala L. Javle MM, et al. Cancer Invest. 2009 Feb;27(2):193-200. doi: 10.1080/07357900802172093. Cancer Invest. 2009. PMID: 19235592 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

238 results

Search Page

Filters